GOSS Gossamer Bio
- 1.020
- +0.050+5.15%
- 1.020
- 0.0000.00%
Gossamer Bio News
12 Health Care Stocks Moving In Thursday's Pre-Market Session
After Plunging -15.92% in 4 Weeks, Here's Why the Trend Might Reverse for Gossamer Bio (GOSS)
Gossamer Bio (GOSS) Gets a Buy From Oppenheimer
Express News | HC Wainwright & Co. Reiterates Buy on Gossamer Bio, Maintains $10 Price Target
Gossamer Bio Analyst Ratings
Promising Progress and Expansion Potential of Gossamer Bio's Seralutinib Drive Buy Rating
Gossamer Bio, Inc. (NASDAQ:GOSS) Just Reported And Analysts Have Been Lifting Their Price Targets
Gossamer Bio Reports Revenue Growth Amid Strategic Collaborations
Gossamer Bio: Q3 Earnings Snapshot
Earnings Flash (GOSS) GOSSAMER BIO Reports Q3 Revenue $9.5M
Gossamer Bio | 10-Q: Q3 2024 Earnings Report
Gossamer Bio | 8-K: Gossamer Bio Announces Third Quarter 2024 Financial Results and Provides Business Update
Gossamer Bio 3Q Loss/Shr 14c >GOSS
Express News | Gossamer Bio Announces Third Quarter 2024 Financial Results and Provides Business Update
Express News | Gossamer Bio Q3 Operating Expenses USD 43.399 Million
Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Express News | Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
Several Insiders Invested In Gossamer Bio Flagging Positive News
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gossamer Bio Management to Meet With Oppenhiemer
No Data